首页 > 市场调查报告书 > 材料

复合材料

市场调查报告书

商品编码

1629860

全球硬脂酸镁市场 - 2024-2031

Global Magnesium Stearate Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 201 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年全球硬脂酸镁市场规模达5.3333亿美元，预计2031年将达到8.5125亿美元，2024-2031年预测期间复合年增长率为6.0%。

硬脂酸镁是硬脂酸的镁盐，广泛用作润滑剂、抗结块剂和脱模剂。它在药品中的应用，特别是作为片剂黏合剂和包衣剂，占其全球需求的很大一部分。此外，硬脂酸镁在确保製造过程的一致性和品质方面的效用也有助于其不断上升的市场份额。

由于硬脂酸镁在药品、化妆品和食品等各行业的使用量不断增加，全球硬脂酸镁市场正在快速成长。根据联合国 (UN) 统计，到 2050 年，全球 65 岁及以上人口预计将翻一番，达到 15 亿。这种人口结构的变化将显着增加药品中硬脂酸镁的需求，因为人口老化需要更多的药物。

在製药和化妆品行业强劲成长的推动下，亚太地区正成为硬脂酸镁成长最快的市场。亚洲开发银行（ADB）表示，随着印度和中国等国家大力投资药品生产，该地区的医疗保健支出预计将大幅增加。

印度品牌公平基金会(IBEF) 报告称，2023 年印度药品出口额超过250 亿美元。创造了巨大的需求用于硬脂酸镁等赋形剂。

动力学

技术进步与扩大应用

硬脂酸镁生产技术的进步显着提高了其品质并拓宽了其应用范围。在製药业，硬脂酸镁可确保片剂的完整性和稳定性，改善药物传递系统。最近的创新，例如微粉化硬脂酸镁，提供卓越的性能和分散特性，满足主要市场严格的监管要求。

在化妆品产业中，硬脂酸镁广泛用作爽身粉、眼影和口红中的质感增强剂。根据 Cosmetics Europe 的数据，欧洲仍然是化妆品和个人护理产品的全球旗舰市场，2023 年零售价约为 950 亿美元。食品和饮料。

品质标准意识不断增强

美国食品药物管理局(FDA)、欧洲药品管理局(EMA) 和世界卫生组织(WHO) 等主要组织建立的监管框架在确保硬脂酸镁产品的安全性和有效性方面发挥至关重要的作用。这些框架强制遵守严格的药典标准，包括美国药典 (USP) 和欧洲药典 (EP) 制定的标准，迫使製造商创新和改进其生产流程。

遵守这些标准不仅可以保证产品质量，还可以创造竞争性的市场环境，激励製造商提高营运效率和产品配方。因此，公司越来越注重满足这些严格的指导方针，以确保其产品不仅符合监管要求，而且满足消费者对更安全、更有效的药用辅料不断变化的需求。

供应链中断和原材料成本上涨

硬脂酸镁主要源自镁，镁是从菱镁矿或白云石等矿物中提取的金属。这些原材料的价格因供应短缺或地缘政治紧张等因素而波动，这会显着影响硬脂酸镁生产的成本结构。作为药品和食品加工中广泛使用的辅料，原材料价格的任何不稳定性都可能导致生产成本增加，影响整体市场动态。

此外，人们对食品添加剂的安全性越来越关注，这可能会导致未来监管更加严格。监管机构越来越多地审查添加剂的使用，以确保消费者安全，这可能给硬脂酸镁市场带来挑战。然而，正在进行的研究和监管批准的建立预计将有效解决这些问题，有助于保持硬脂酸镁在各种应用中提供的安全性和功能性优势之间的平衡。

Magnesium stearate, a magnesium salt of stearic acid, is extensively utilized as a lubricant, anti-caking agent and release agent. Its applications in pharmaceuticals, particularly as a tablet binder and coating agent, account for a significant portion of its global demand. Furthermore, magnesium stearate's utility in ensuring consistency and quality in manufacturing processes contributes to its rising market share.

The global magnesium stearate market is witnessing rapid growth, driven by its increasing use across various industries such as pharmaceuticals, cosmetics and food. According to the United Nations (UN), the global population aged 65 and above is expected to double by 2050, reaching 1.5 billion. This demographic shift will significantly increase the demand for magnesium stearate in pharmaceuticals, as aging populations require more medications.

Asia-Pacific is emerging as the fastest-growing market for magnesium stearate, driven by robust growth in the pharmaceutical and cosmetics industries. According to the Asian Development Bank (ADB), the region's healthcare expenditure is expected to rise significantly, with countries like India and China investing heavily in pharmaceutical production.

The India Brand Equity Foundation (IBEF) reports that India's pharmaceutical exports surpassed US$ 25 billion in 2023. The country exported US$ 2.43 billion worth of drugs and pharmaceuticals in April 2024 alone, up from US$ 2.26 billion in April 2023 creating substantial demand for excipients like magnesium stearate.

Dynamics

Technological Advancements and Expanding Applications

Technological advancements in magnesium stearate production have significantly enhanced its quality and broadened its application spectrum. In the pharmaceutical industry, magnesium stearate ensures tablet integrity and stability, improving drug delivery systems. Recent innovations, such as micronized magnesium stearate, offer superior performance and dispersion properties, meeting stringent regulatory requirements in key markets.

In the cosmetics industry, magnesium stearate is widely used as a texture-enhancing agent in face powders, eye shadows and lipsticks. According to Cosmetics Europe, Europe remains a global flagship market for cosmetics and personal care products, approximately valued at US$ 95 billion in retail sales price in 2023. The food industry also relies on magnesium stearate as an additive to prevent ingredient clumping, particularly in powdered foods and beverages.

Rising Awareness of Quality Standards

Regulatory frameworks established by key organizations such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and the World Health Organization (WHO) play a crucial role in ensuring the safety and effectiveness of magnesium stearate products. These frameworks enforce compliance with stringent pharmacopeial standards, including those set by US Pharmacopeia (USP) and the European Pharmacopoeia (EP), which compel manufacturers to innovate and refine their production processes.

Adherence to these standards not only guarantees product quality but also fosters a competitive market environment where manufacturers are incentivized to enhance their operational efficiencies and product formulations. As a result, companies are increasingly focusing on meeting these rigorous guidelines to ensure that their products not only comply with regulatory requirements but also meet the evolving demands of consumers for safer and more effective pharmaceutical excipients.

Supply Chain Disruptions and Rising Raw Material Costs

Magnesium stearate is primarily sourced from magnesium, a metal extracted from minerals such as magnesite or dolomite. The prices of these raw materials fluctuate due to factors like supply shortages or geopolitical tensions, which can significantly affect the cost structure of magnesium stearate production. As a widely used excipient in pharmaceuticals and food processing, any instability in raw material pricing can lead to increased production costs, impacting the overall market dynamics.

Additionally, there is growing concern regarding the safety of food additives, which may result in stricter regulations in the future. Regulatory bodies are increasingly scrutinizing the use of additives to ensure consumer safety, potentially posing challenges for the magnesium stearate market. However, ongoing research and the establishment of regulatory approvals are expected to address these concerns effectively, helping to maintain the balance between safety and the functional benefits that magnesium stearate provides in various applications.

Segment Analysis

The global magnesium stearate market is segmented based on application, end-user and region.

Increasing Demand from the Pharmaceutical Sector

The pharmaceutical industry is the largest consumer of magnesium stearate. This excipient plays a vital role in drug formulation, particularly due to its ability to enhance the compressibility and flowability of active pharmaceutical ingredients (APIs). As the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) projects that the biopharmaceutical market will exceed US$ 1.750-1.780 trillion by 2026, the demand for magnesium stearate is expected to rise significantly, reinforcing its status as a critical component in modern drug manufacturing.

Magnesium stearate serves multiple functions in pharmaceutical applications, primarily acting as a lubricant that reduces friction between particles during the manufacturing process. This property is essential for ensuring efficient production of tablets and capsules, as it prevents ingredients from sticking to machinery and promotes consistent dosing. Additionally, magnesium stearate aids in improving the flow properties of drug powders, which is crucial for handling and processing during production. Its indispensable role in enhancing the quality and efficacy of pharmaceuticals underscores its importance in the industry.

Geographical Penetration

Strong Consumer Awareness in North America

North America dominates the magnesium stearate market, largely due to its robust pharmaceutical and food processing industries. The U.S. Food and Drug Administration (FDA) plays a critical role in this sector by emphasizing the necessity for high-quality excipients, which compels domestic manufacturers to adhere to stringent compliance and quality standards. According to the Centers for Medicare & Medicaid Services, in the U.S. healthcare spending grew 4.1% in 2022, reaching US$ 4.5 trillion or US$ 13,493 per person, highlighting the substantial demand for magnesium stearate within these industries.

The focus on magnesium stearate's quality is further reinforced by the FDA's regulations, which require manufacturers to ensure that their excipients meet the standards set by US Pharmacopeia (USP) and National Formulary (NF). This regulatory oversight is crucial as it not only safeguards patient safety but also maintains the integrity of drug formulations. Consequently, manufacturers are increasingly investing in quality assurance processes to comply with these regulations, ensuring that magnesium stearate and other excipients are safe and effective for use in pharmaceutical applications.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, PT Halim Sakti Pratama, Parchem Fine & Specialty Chemicals, Nimbasia, Baerlocher GmbH, Valtris Specialty Chemicals, FACI SPA, Merck KGaA, Kirsch Pharma GmbH and James M. Brown Ltd.

Sustainability Analysis

The magnesium stearate market is increasingly prioritizing sustainability as manufacturers adopt energy-efficient processes and explore biodegradable formulations. These initiatives are crucial for meeting global sustainability goals and responding to rising consumer demand for eco-friendly products. According to the Global Sustainability Council for Chemicals (GSCC), the shift towards sustainable practices is not just a trend but a necessary evolution in the industry, aligning with broader environmental objectives.

Leading companies in the magnesium stearate sector are focusing on innovative production methods that minimize environmental impact. This includes the use of renewable resources and the development of formulations that reduce reliance on non-biodegradable materials. As sustainability becomes a key factor in purchasing decisions, manufacturers recognize the importance of adapting to these changes to remain competitive and relevant in a market that increasingly values ecological responsibility.

Advanced Material Innovations in the Magnesium Stearate Market

Innovations in material science and production processes are significantly shaping the magnesium stearate market. One of the most notable innovations in the magnesium stearate market is the development of nano-formulations. The ultra-fine particles of magnesium stearate enhance the flowability and uniformity of powders used in tablet and capsule manufacturing. The use of nano-sized magnesium stearate improves the consistency of active pharmaceutical ingredients (APIs) in solid dosage forms, ensuring better performance and drug release characteristics.

Similarly, innovations in drug delivery systems, such as controlled and sustained-release formulations, are driving the demand for specialized grades of magnesium stearate. Advanced drug formulations that require precise control over the release rate of the active ingredient benefit from the lubrication properties of magnesium stearate. New formulations are being developed to improve their compatibility with different types of APIs, including those that are poorly soluble in water, to enhance the bioavailability and therapeutic effectiveness of drugs.

By Application

Lubricants
Binders and Fillers
Emulsifiers
Stabilizers
Others

By End-User

Pharmaceutical
Food & Beverage
Personal Care
Plastics
Other

By Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In August 2023, Peter Greven, a leading producer of oleochemical additives and auxiliary products, made a strategic move to strengthen its foothold in the Chinese market. The company announced the purchase of a new plant for the production of magnesium stearate, a move that is expected to enhance its position in China across several product categories.
In September 2023, Elite Chemicals, a renowned pharmaceutical company, announced the launch of a new line of magnesium stearate products specifically designed for the food industry. These products are gluten-free and non-GMO, addressing the evolving needs of the food sector, where clean labels and healthy ingredients are becoming increasingly important.
On August 2, 2022, SK Capital Partners, a private investment firm based in New York with a focus on specialty chemicals, materials and pharmaceuticals, announced the completion of its acquisition of Valtris Specialty Chemicals from H.I.G. Capital. The acquisition strengthens SK Capital's portfolio in the specialty chemicals sector and is expected to drive further innovation and market expansion for Valtris, particularly in the development of key chemical products such as magnesium stearate.

Why Purchase the Report?

To visualize the global magnesium stearate market segmentation based on application, user and region.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points at the magnesium stearate market level for all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global magnesium stearate market report would provide approximately 54 tables, 46 figures and 201 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Application
3.2. Snippet by End-User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements and Expanding Applications
  - 4.1.1.2. Rising Awareness of Quality Standards
- 4.1.2. Restraints
  - 4.1.2.1. Supply Chain Disruptions and Rising Raw Material Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. By Application

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 6.1.2. Market Attractiveness Index, By Application
6.2. Lubricants*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Binders and Fillers
6.4. Emulsifiers
6.5. Stabilizers
6.6. Others

7. By End-User

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.1.2. Market Attractiveness Index, By End-User
7.2. Pharmaceutical*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Food & Beverage
7.4. Personal Care
7.5. Plastics
7.6. Other

8. Sustainability Analysis

8.1. Environmental Analysis
8.2. Economic Analysis
8.3. Governance Analysis

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. US
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Thermo Fisher Scientific*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. PT Halim Sakti Pratama
11.3. Parchem Fine & Specialty Chemicals
11.4. Nimbasia
11.5. Baerlocher GmbH
11.6. Valtris Specialty Chemicals
11.7. FACI SPA
11.8. Merck KGaA
11.9. Kirsch Pharma GmbH
11.10. James M. Brown Ltd

LIST NOT EXHAUSTIVE

12. Appendix

12.1. About Us and Services
12.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球硬脂酸镁市场 - 2024-2031

Global Magnesium Stearate Market - 2024-2031

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：按申请

第 7 章：最终用户

第 8 章：可持续性分析

第 9 章：按地区

第 10 章：竞争格局

第 11 章：公司简介

第 12 章：附录